Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oestrogen and vascular disease.

P Harvey1

  • 1Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, SA.

Australian and New Zealand Journal of Medicine
|June 27, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of Reactor Antineutrino Oscillation at SNO.

Physical review letters·2025
Same author

The therapist experience of internet delivered CBT for problem gambling: Service integration considerations.

Internet interventions·2020
Same author

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Lupus·2018
Same author

Antimalarial-induced cardiomyopathy: a systematic review of the literature.

Lupus·2017
Same author

GAMBLINGLESS: FOR LIFE study protocol: a pragmatic randomised trial of an online cognitive-behavioural programme for disordered gambling.

BMJ open·2017
Same author

Osteoarthritis-related difficulty walking and risk for diabetes complications.

Osteoarthritis and cartilage·2016

Estrogen may protect postmenopausal women from cardiovascular disease (CVD) by improving lipid profiles and vasodilation. However, progestogens may counteract these benefits, necessitating further research on hormone replacement therapy (HRT) effects.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is a primary cause of death in postmenopausal women.
  • Epidemiological studies suggest estrogen reduces CVD risk by 30-50% in this population.
  • The cardiovascular effects of combined estrogen-progestogen therapy remain unclear.

Purpose of the Study:

  • To review the evidence for estrogen's cardioprotective effects in postmenopausal women.
  • To explore potential mechanisms of estrogen-induced cardioprotection.
  • To discuss the potential impact of progestogens on estrogen's cardiovascular benefits.

Main Methods:

  • Review of epidemiological studies and biological mechanisms.
  • Analysis of data on estrogen's effects on lipid metabolism, insulin resistance, and fibrinolysis.

Related Experiment Videos

  • Examination of estrogen's impact on vascular structure and function, including vasodilation, anti-atherogenic, and antioxidant properties.

    • Main Results:

    • Estrogen demonstrates plausible cardioprotective mechanisms, including favorable lipid changes and vasodilation.
    • Estrogen may improve insulin resistance and fibrinolytic activity.
    • Progestogens, particularly those with androgenic properties, may negate estrogen's beneficial cardiovascular effects.

    Conclusions:

    • Estrogen exhibits multiple mechanisms supporting cardioprotection in postmenopausal women.
    • Progestogens may attenuate or oppose estrogen's positive cardiovascular actions.
    • Further research is needed to clarify the effects of various hormone replacement therapy formulations on cardiovascular outcomes.